PMID: 27428472

The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients.

Zeidan B, Anderson K, Peiris L, Rainsbury D, Laws S

Breast (Edinburgh, Scotland) · 2017

Vol. 29, pp. 62-7

View on PubMedDOI

This entry links to third-party literature. For research use only.

AdultAgedAged, 80 and overAntineoplastic Agents, HormonalBreast NeoplasmsChi-Square DistributionDrug SubstitutionDrug-Related Side Effects and Adverse ReactionsDrugs, GenericFemale

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.